Tag: metastatic melanoma

OncoSec Medical begins phase 2 OMS-104 melanoma trial with TAVO, OPDIVO combo

pharmanewsdaily- January 10, 2021

OncoSec Medical has dosed the first patient in the OMS-104 phase 2 clinical trial, which is evaluating TAVO (tavokinogene telseplasmid) in combination with OPDIVO (nivolumab) ... Read More